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Background: Patients' experience with health care is becoming a key
component for the provision of a patient-centered health care model. The
aim of this study was to assess the experience with health care of patients
with inflammatory arthritis and patient- and health care–related factors.
Methods: Patients responded to an anonymous survey provided by their
treating clinical teams. The survey comprised the validated 12-item IEXPAC
(Instrument to Evaluate the EXperience of PAtients with Chronic diseases)
tool and demographic variables and health care–related characteristics that
may affect patients' experience.
Results: A total of 359 of 625 surveys were returned (response rate,
57.4%). Overall, patient responses were positive (>60% gave “always/
mostly” answers) for statements assessing the interaction between patients
and health care professionals or patient self-management following health
care professional guidance. However, positive patient responses for items
regarding patient interaction with the health care system via the internet or
with other patientswere less than 13%.Only 25.6% of patientswho had been
hospitalized reported receiving a follow-up call or visit following discharge.
In the bivariate analysis, experience scores were higher (better experience) in
men, those seen by fewer specialists or by the same physician, and in patients
treated with a fewer number of drugs or with subcutaneous/intravenous drugs.
Multivariate analyses identified regular follow-up by the same physician and
treatment with subcutaneous/intravenous drugs as variables associated with
a better patient experience.
Conclusions: This study identifies areas of care for patients with inflam-
matory arthritis with the potential to improve patients' experience and high-
lights the importance of patient-physician relationships and comprehensive
patient care.
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P atients' experience with health care is a key component for theprovision of a patient-centered health care model, as both
clinical effectiveness and patients' safety are correlated positively
with patients' experience.1 In patients with chronic conditions, a more
positive patient experience is associated with improved quality of
care,2 with the interaction of patients with health care professionals,
particularly general practitioners, being important for patient well-
being.3 Effective chronic illness management also depends on multi-
disciplinary care teams, including nurses and pharmacists, with
clinical and behavioral skills.4
Rheumatic diseases affect a significant proportion of the
population and are a major cause of disability worldwide, adversely
affecting quality of life and causing lost productivity and increased
health care costs.5,6 We have reported previously the outcomes of a
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survey to assess the experience of patients with 4 different chronic
conditions (i.e., inflammatory arthritis, inflammatory bowel disease
[IBD], human immunodeficiency virus [HIV] infection, and dia-
betes mellitus) with health care using the Instrument to Evaluate
the EXperience of PAtients with Chronic diseases (IEXPAC) tool.7
IEXPAC is a validated questionnaire developed in Spain with
several advantages over other available questionnaires (namely,
a focus on the overall interaction of patients with the health care
system and not with specific professionals and the inclusion of
a broader notion of integrated care, including social care, patients'
self-management, new technological interventions, and patients' in-
teractions with other patients).8 In the previously mentioned study,7
patients with HIV infection described better experience with health
care than patients with other chronic diseases. Because approaches
to patients' care can differ based on patient-specific chronic condi-
tions, we deemed it of interest to perform an analysis of specific
patient profiles. In this work, we focus on the cohort of patients
with inflammatory arthritis, with the objective of describing pa-
tient perceptions of health care, identifying the main areas for
improvement, and assessing potential variables affecting patient
experience (including demographic variables and health care–
related characteristics).
METHODS
This was a cross-sectional survey of patients with chronic
conditions, and the present substudy focuses on the subset of patients
with inflammatory arthritis. This subgroupwas constituted of patients
older than 18 years with rheumatoid arthritis, axial spondyloarthritis,
or psoriatic arthritis, receiving health care in rheumatology clinics
from 25 participating hospital clinics across Spain. Twenty-five con-
secutive patients attending each clinic were handed a survey by their
clinical teams,which included the IEXPACquestionnaire as its focus,
and they were instructed to voluntarily complete and return it from
home by prepaid post mail. This patient cohort was part of a larger
study of 4 chronic diseases comprising inflammatory arthritis,
diabetes mellitus, IBD, and HIV infection. The study protocol,
methodology, and main outcomes for the overall population have
been described elsewhere.7 The protocol, instructions for patients,
and survey content were reviewed and approved by the Clinical
Research Ethic Committee of the Gregorio Marañón Hospital of
Madrid, Spain. Because of the anonymous nature of the survey,
and as agreed by the Clinical Investigation Ethics Committee,
the voluntary return of completed surveyswas taken as patient im-
plied consent to participate in the survey. There was no collection
of data from the patients' medical records.
Survey Instrument
The survey included the IEXPAC questionnaire mainly, plus
additional multiple-choice questions providing information on pa-
tient demographics, and health care– and treatment-related char-
acteristics. The survey was drafted by expert physicians with the
input of patients with the aforementioned chronic conditions and
was endorsed by the Spanish Association of Patients with Arthri-
tis (CONARTRITIS) and other patients' associations.7 The entire
survey is provided as supplementary material (Supplemental Dig-
ital Content 1, http://links.lww.com/RHU/A159).
Details of the IEXPAC questionnaire have been published.8
Briefly, IEXPAC is a 12-item questionnaire with patient responses
made using a 5-point Likert scale ranging from “always” (score 10)
to “never” (0). An overall score is given by summing the scores of
items 1 to 11 and dividing by 11, which describe patient experience
within the last 6 months. Item 12, describing hospitalization in the
last 3 years, is reported separately. Three factors are derived from
IEXPAC items 1 to 11. Factor 1 (productive interactions) refers to
the content and characteristics of interactions between patients
and health care professionals and is the mean score of items 1, 2,
5, and 9. Factor 2 (new relational model) refers to new forms of
patient interaction with the health care system through the internet
or with peers and is the mean score of items 3, 7, and 11. Factor 3
(patient self-management) is the ability of individuals to manage
their own care and improve their well-being based on health care
professional–mediated interventions and is the mean score of
items 4, 6, 8, and 10.
Statistical Analysis
This is an exploratory study with no formal hypothesis or
prespecified sample size. A conservative approach was adopted
to calculate each cohort sample size based on a qualitative variable
with an expected prevalence of 50%, 95% confidence interval,
and with 6% precision. This approach gave an initial calculated
sample size of 267 patients, plus 15% of variables completed incor-
rectly (314 patients), and accounting for an expected response rate
of approximately 50%, as found in other surveys handed to patients
by clinical teams,9,10 to give a total sample size of 628 patientswith
rheumatic diseases.
Descriptive information is displayed as mean and SD for
quantitative variables, and frequencies or percentages for qualita-
tive variables. The results of the IEXPAC questionnairewere calcu-
lated as overall mean (SD) score and mean (SD) scores for factors
1 to 3. The distribution of responses to each item is also displayed,
as well as the mean score for each item.
The χ2 or the Fisher exact tests were used for comparison of
proportions, and the Student t test or analysis of variance used to
compare continuous variables. Multiple linear regression models
were used to assess different demographic and health care–related
variables influencing the IEXPAC overall score and individual
factor scores. Given the overall descriptive nature of the results,
no multiplicity adjustments were made, and there was no imputa-
tion for missing data.
RESULTS
Description of the Sample
Surveys were distributed and collected between May and
September 2017. A total of 359 of 625 surveys handed out to pa-
tients with inflammatory arthritis were returned (response rate,
57.4%). Patients' demographic and health care–related characteris-
tics are presented in Table 1. The mean (SD) age of respondents
was 54.6 (13.9) years; 63.3% were women. Only 6.2% were affil-
iated to a patient's association, and 67.7% searched for information
about health care from sources different from those provided by
health care providers. For 7.9% of patients, follow-up for health
care required visiting a Spanish region different from their residing
region. Themean (SD) number of different specialists visited in the
past year was 4.3 (2.6), with primary care physicians (81.6%) vis-
iting most frequently. Patient follow-up was commonly performed
by the same physician (84.9% of patients), whereas for nearly half
of patients (49.0%), follow-up was also done by a nurse. Support
from non–health care workers (relatives or friends, caregiver) for
health carewas received by 46.8% of patients. Themean (SD) num-
ber of medicines taken daily was 4.4 (2.6), and 58.5% of patients
received subcutaneous (SC) or intravenous (IV) medications. The
proportion of patients hospitalizedwithin the past 3 yearswas 41.2%.
IEXPAC Responses and Experience Scores
The distribution of patients' responses to the 12 IEXPAC
items and the mean score of each item are shown in Table 2.
The proportion of patients who responded “always” or “mostly”
to items related to factors 1 (productive interactions score) and 3
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(self-management score) were greater than 60%, except for item
10 (informed on the health and social resources, 33.8%). Factor
2 (new relational model) items showed a low proportion of “al-
ways/mostly” responses (<13%). Only 25.6% of patients who
had been hospitalized in the past 3 years reported to have re-
ceived a follow-up call or visit after discharge.
The mean (SD) overall IEXPAC score was 5.5 (2.0). Mean
(SD) scores were higher for factors 1 (productive interactions score,
7.5 [2.5]) and 3 (self-management score, 6.5 [2.5]) than for factor 2
(new relational model: 1.7 [2.1]). IEXPAC experience scores strat-
ified by different demographic and health care–related variables are
shown in Supplemental Digital Content 2, http://links.lww.com/
RHU/A160, and a summary of the bivariate analysis is shown in
Table 3. Men had slightly higher overall score (p = 0.022) and higher
scores for factors 1 (productive interactions, p = 0.013) and 3 (patient
self-management, p = 0.024). Productive interactions and self-
management factor scores were higher in aged patients (p linear
trend = 0.033 and 0.041, respectively). New relational model
factor (factor 2) scores were higher in patients with higher edu-
cational level (p linear trend = 0.028).
With regard to health care characteristics, patients followed up
in a region different from their home region scored higher in the over-
all score (p = 0.004) and in the new relational model (p < 0.001) and
self-management (p = 0.048) factors. Overall score and productive
interactions and self-management factor scores were higher in pa-
tients seen by a smaller number of specialists (p linear trend = 0.025,
0.017, and 0.040, respectively) and in those followed up by the
same physician compared with follow-up by different physicians
(p < 0.001 in all cases). Scores were similar for patients who had
follow-up by a nurse compared with no nurse follow-up.
Finally, the overall experience score and the productive inter-
actions score were higher in patients treated with a lower number
of drugs (p linear trend = 0.039 and 0.005, respectively) and in
those treated with SC or IV drugs, but these failed to reach statis-
tical significance (p = 0.083 and 0.099, respectively).
Multivariate Analysis
Results of multiple linear regression analyses are shown in
Table 4. Factors associated with higher overall IEXPAC score (in-
dicating a better experience) were being followed regularly by the
same physician (p = 0.001) and received treatment with SC or IV
drugs (p = 0.021). These variables were also associated with better
productive interactions (p < 0.001 and p = 0.013, respectively) and
self-management (p < 0.001 and 0.040, respectively) scores. As-
sociations between a lower number of specialists and higher
IEXPAC scores, or betweenmale gender and higher factor 1 score,
did not reach statistical significance by multivariate analysis.
DISCUSSION
This study describes the health care experience of adult
patients with inflammatory arthritis (rheumatoid arthritis, axial
spondyloarthritis, or psoriatic arthritis) using the IEXPAC ques-
tionnaire,8 identifying not only positive aspects of patient experi-
ence but also areas for improvement. Overall, patient responses
were much more positive for factors 1 (productive interactions)
and 3 (self-management) than for the new relational model factor.
Most patients (>60%) provided positive responses (“always/
mostly”) for 7 of the 8 items in factors 1 and 3. The exception
was item 10 (patient information on health and social resources),
where only a third of patients gave positive responses. This is in
broad agreement with an Italian study of patients with rheumatic
diseases where only 37% were satisfied with the information pro-
vided during treatment.11
Positive patient responses for the 3 items in the new relational
model factor were less than 13%. The low percentage of patients
who responded “always/mostly” to the statement “They help me
to get information from the internet” identifies a clear area of im-
provement given that, in this study, two-thirds of these patients
declared searching information in sources different to health care
providers. In addition, approximately only a quarter of patients
who had been hospitalized reported having received a follow-up
call or visit following discharge, but more than 40% had been hos-
pitalized in the past 3 years. Thus, there seems to be a need for
more proactive communication from health care professionals to
patients after discharge from hospitalization.
In an analysis of the overall study population,7 only 6.1% of
patients reported being affiliated with a patient's association; simi-
larly, in the current subgroup of patients with inflammatory arthritis,
only 6.2%of patientswere affiliatedwith a patient's association. Af-
filiation with patients' associations has not been frequent in the past
in Spain, but it is increasing as communication channels are more
TABLE 1. Patient Demographics and Health Care–Related
Characteristics of Patients Who Completed the Survey (n = 359)
Parameter Value
Patient demographics
Age, mean (SD), y 54.6 (13.9)
Sex, women, % 63.3
Educational level achieved
Primary, % 43.8
Secondary, including vocational, % 32.5
University or further, % 23.6
Barthel Index of Activities of Daily Living,
Barthel ≤80, %
13.2
Affiliated to patients' association, % 6.2
Searched for information about health care from
sources different from health care providers
(i.e., internet, media, etc.), %
67.7
Health care–related characteristics
Follow-up for health care in a Spanish region
different from the patient's main residence, %
7.9
No. of different specialists (including primary
care) visited in the past year, mean (SD)a
4.3 (2.6)
1–2 specialists, % 24.0
3–4 specialists, % 36.8
≥5 specialists, % 39.2
Patient follow-up is usually done by the
same physician?
Generally, the same physician, % 84.9
Sometimes different, % 11.2
Frequently different, % 3.9
Follow-up by a nurse, % 49.0
Support from others (relatives or friends,
caregiver) for health care, %
46.8
Treatment-related characteristics
No. medicines taken daily, mean (SD) 4.4 (2.6)
0–2 medicines, % 26.3
3–4 medicines, % 34.3
≥5 medicines, % 39.4
Treated with SC or IV medications, % 58.5
Hospitalization within the past 3 y, % 41.2
aSpecialists visited most frequently were primary care physician
(81.6%), ophthalmologist (32.9%), dermatologist (24.8%), gynecologist
(24.2%), and orthopedic surgeon (22.3%).
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accessible and patients perceive the benefits of being affiliated.
Clearly, the higher the proportion of patients who are affiliated with
patients' associations, the more likely it is that patient-patient
communication will be facilitated, increasing the opportunities
for productive interactions with other patients. This highlights
the importance of implementing actions (e.g., educating patients
about the activities and advantages of patients' associations) to
establish productive communication with other patients, starting
with good physician-patient communication.12–14
Both bivariate and multivariate analyses identified that regu-
lar follow-up by the same physician was associated with a better
patient experience. This demonstrates the importance of building
good patient-physician relationships, which may aid communica-
tion. Interestingly, there was no association between follow-up by
nurses and a better patient experience. In contrast, in the cohort of
IBDpatients, follow-up by nurseswas associatedwith a better patient
experience.15 This difference may be due to nurse specialization in
IBD clinics. Rheumatic patients in the current study were recruited
from general hospital rheumatology clinics, which deal with more
clinically diverse diseases, where nurses are not necessarily spe-
cialized in inflammatory arthritis. However, a better experience
was identified for rheumatic disease patients treated with SC/IV
drugs, which may be due to more personalized care, involving
not only physicians but also pharmacists and nurses, and easier
access to their clinical teams. Therefore, the role of nurses is very
relevant, at least in this subset of patients treated with SC/IV
drugs, in which nurses have a role in training patients in the use
of devices, preparing them for IV infusions, or in the follow-up
of drug tolerability or adherence. In another survey, patients with
rheumatic diseases who were receiving SC biological therapy re-
ported high treatment satisfaction, but also reported that the clin-
ical teams failed to address personal problems derived from their
TABLE 2. Patient Responses (%) and Mean Scores for Each IEXPAC Item
IEXPAC Item
Patient Responses (%) Mean
Score (SD)Always Mostly Sometimes Seldom Never
1. They respect my lifestyle
The professionals who care of me listen to me and ask me about my needs,
habits, and preferences to adapt my treatment and care plan.
49.3 27.2 15.8 5.2 2.6 7.9 (2.6)
2. They are coordinated to offer good health care to me
Health and social care services are coordinated to improve my well-being and
quality of life in my environment (family, neighborhood, town).
37.0 23.6 15.8 7.5 16.1 6.4 (3.6)
3. They help me to get information from the internet
The professionals who care for me inform me about trustful web pages and
internet forums that I can consult to know my disease better, its treatment,
and the consequences they may have on my life.
5.5 7.1 12.8 15.1 59.3 2.1 (3.1)
4. Now I can take care of myself better
I feel that my confidence in my ability to take care of myself, manage my
health problems, and keep my autonomy has improved.
41.5 32.8 21.5 1.8 2.4 7.7 (2.4)
5. They ask me and help me to follow my treatment plan
I regularly review adherence to my treatment and care plan with the
professionals who care for me.
53.3 20.2 14.0 6.8 5.7 7.7 (3.0)
6. We set goals for a healthy life and better control my illness
I've been able to agree with the professionals who care for me on specific
objectives regarding diet, physical exercise, and medication to get better
control of my health problems.
41.4 22.0 15.2 7.7 13.7 6.7 (3.6)
7. I can use the internet and my mobile phone to consult my medical records
I can consult my clinical record, tests results, programmed visits, and access to
other services through the internet or the mobile app of my health service.
4.0 3.3 5.5 7.3 79.9 1.1 (2.5)
8. They make sure that I take medication correctly
The professionals who care for me review with me all of the medication I take,
how I take it, and how it suits me.
54.6 17.8 7.7 6.2 13.6 7.3 (3.6)
9. They worry about my welfare
The professionals who care for me are concerned with my quality of life, and
I feel they are committed to my well-being,
60.3 18.8 13.4 3.0 4.5 8.1 (2.7)
10. I have been informed on health and social resources that can help me
The professionals who care for me inform me about health and social
resources available in my neighborhood or town that I can use to improve
my health problems and take better care of myself.
21.1 12.7 14.8 13.6 37.8 4.1 (4.0)
11. They encourage me to talk to other patients
The professionals who care for me invite me to participate in patient groups to
share information and experiences on how to care for ourselves and improve
our health.
6.1 4.2 13.9 12.4 63.3 1.9 (3.0)
Respond to the following statement only if you have been admitted to the
hospital in the last 3 y
12. They care about me when I come home after being in the hospital
After hospital discharge, they have called or visited me at home to see how
I was and what care I needed.
18.2 7.4 8.8 6.1 59.5 3.0 (4.0)
“Productive interactions” factor: items 1, 2, 5, and 9; “new relational model” factor: items 3, 7, and 11; “patient self-management” factor: items 4, 6, 8, and 10.
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rheumatic diseases.10 Findings from these studies suggest the im-
portance of a holistic approach, focusing not solely on the disease
but on the patient as a person, to improve his/her experience with
health care.
We have previously described the limitations of this study.7
Because anonymous surveys preclude characterization of the
nonrespondent population, we cannot rule out a certain selection
bias to patients with better experience with their health care, who
could have been more likely to respond. For the present cohort, we
selected patients with rheumatoid arthritis, axial spondyloarthritis,
or psoriatic arthritis to ensure we covered a proportion of patients re-
ceiving SC/IV drugs, likely to receive different care from those re-
ceiving only oral drugs. However, patients did not identify their
rheumatic condition in the survey, and consequently, we cannot draw
conclusions for specific diseases or for patients with other rheumatic
diseases such as vasculitis or connective tissue diseases. Finally, the







Model Score (Factor 2)
Patient Self-management
Score (Factor 3)
Age — Oldera — Oldera
Gender Men Men — Men
Educational level achieved — Lowera,b Highera —
Barthel Index >80 — — — —
Follow-up in a region different from
home region (vs. same region)
Different — Different Different
No. specialists visited in the past year Lowera Lowera — Lowera
Follow-up by the same physician
(vs. different)
Same physician Same physician — Same physician
Follow-up by a nurse (vs. no nurse
follow-up)
— — — —
Having help from others for health
care (vs. self-care only)
— — — —
No. different medicines taken Lowera Lowera — —
Being treated with SC/IV drugs
(vs. no SC/IV treatment)
— — — —
The table displays the values of the variables associated with better experience scores in the bivariate analysis (p < 0.05).
aDenotes a linear trend.
bp = 0.055.


















Sex (women vs. men) −0.43 (0.28) 0.132 −0.65 (0.36) 0.073 −0.13 (0.30) 0.663 −0.46 (0.35) 0.189
Age (per year of increment) 0.00 (0.01) 0.715 0.01 (0.01) 0.682 −0.00 (0.01) 0.886 0.01 (0.01) 0.659
Educational level achieved
(university or further)
−0.02 (0.19) 0.933 −0.28 (0.24) 0.251 0.32 (0.20) 0.112 −0.03 (0.23) 0.886
Follow-up in a region different
from home region (vs. same region)
0.62 (0.54) 0.252 0.09 (0.68) 0.896 1.11 (0.57) 0.053 0.78 (0.67) 0.243
Barthel Index >80 0.28 (0.37) 0.451 0.26 (0.47) 0.578 0.48 (0.39) 0.226 0.27 (0.46) 0.554
No. specialists visited in the last year
(per unit of increment)
−0.12 (0.07) 0.080 −0.14 (0.08) 0.082 −0.05 (0.07) 0.447 −0.12 (0.08) 0.122
Follow-up by the same physician
(vs. different)
0.84 (0.26) 0.001 1.17 (0.33) <0.001 0.08 (0.27) 0.773 1.15 (0.32) <0.001
Follow-up by a nurse (vs. no nurse
follow-up)
0.10 (0.29) 0.738 −0.08 (0.37) 0.822 0.43 (0.31) 0.167 −0.04 (0.36) 0.914
Having help from others for health
care (vs. only self-care)
0.30 (0.30) 0.308 0.09 (0.38) 0.809 0.42 (0.32) 0.189 0.49 (0.36) 0.178
No. different medicines (per unit
of increment)
−0.03 (0.06) 0.580 −0.05 (0.07) 0.454 0.01 (0.06) 0.927 0.00 (0.07) 0.958
Being treated with SC/IV drugs
(vs. no SC/IV treatment)
0.64 (0.27) 0.021 0.87 (0.35) 0.013 0.32 (0.29) 0.275 0.69 (0.33) 0.040
Positive coefficients indicate higher IEXPAC experience scores.
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current sample represents a balanced distribution of the population of
the different regions of Spain, but the sample size is not powered to
detect differences among regions; this would require a much larger
sample size.
In conclusion, this study has identified areas of rheumatic dis-
ease care with potential to improve patients' experiences if properly
addressed, such as patient interaction with the health care system via
the internet or with peers, provision of patient information on health
and social resources, and closer follow-up after hospital discharge.
The study also highlights the importance of patient-physician rela-
tionships and a comprehensive multidisciplinary approach.
KEY POINTS
• Using the validated 12-item IEXPAC tool, we assessed the ex-
periencewith health care of patients with inflammatory arthritis.
• Overall, patient responses were positive regarding the interaction
between patients and health care professionals or patient self-
management following health care professional guidance, but not
for patient interaction with the health care system via the internet
or with other patients and for follow-up after hospital discharge.
• Being followed up by the same physician and treatment with
SC/IV drugs were associated with better patients' experience
with health care.
• Our study highlights the importance of patient-physician rela-
tionships and comprehensive patient care and identifies areas
of care for patients with inflammatory arthritis with the potential
to improve patient experience.
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